Epigenetics: The role of methylation in the mechanism of action of tumor suppressor genes

被引:34
作者
Jain, PK [1 ]
机构
[1] US FDA, DETTD, OBRR, CBER, Rockville, MD 20852 USA
来源
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT | 2003年 / 983卷
关键词
epigenetics; hypermethylation; tumor suppressor genes; histone deacetylase (HDAC); histone methylase (HMT);
D O I
10.1111/j.1749-6632.2003.tb05963.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetics is the study of mitotically heritable changes in gene expression without any changes in the primary DNA sequence. The major step in epigenetic gene regulation is gene inactivation by hypermethylation of CpG islands located in the promoter region. Specific enzymes and methylated DNA binding proteins play a major role in causing reduced expression of tumor suppressor genes, resulting in tumor formation and its progression. Prevention approaches are needed to avoid tumor formation. One approach to inhibiting inactivation of tumor suppressor genes is to use chemical agents such as 5-azacytidine to prevent hypermethylation of DNA. Increased understanding of the mechanism of epigenetic silencing and the identification of additional molecular mechanisms (e.g., histone methylases) that may be targeted by pharmaceutical interventions may lead to more preventive strategies. The current status of the epigenetic regulation of tumor suppressor genes is discussed in this review article.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 81 条
[11]   Methylation-induced repression - Belts, braces, and chromatin [J].
Bird, AP ;
Wolffe, AP .
CELL, 1999, 99 (05) :451-454
[12]  
BOUCHARD J, 1983, MOL PHARMACOL, V24, P109
[13]   DNA METHYLATION INHIBITS TRANSCRIPTION INDIRECTLY VIA A METHYL-CPG BINDING-PROTEIN [J].
BOYES, J ;
BIRD, A .
CELL, 1991, 64 (06) :1123-1134
[14]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107
[15]   AMOUNT AND DISTRIBUTION OF 5-METHYLCYTOSINE IN HUMAN DNA FROM DIFFERENT TYPES OF TISSUES OR CELLS [J].
EHRLICH, M ;
GAMASOSA, MA ;
HUANG, LH ;
MIDGETT, RM ;
KUO, KC ;
MCCUNE, RA ;
GEHRKE, C .
NUCLEIC ACIDS RESEARCH, 1982, 10 (08) :2709-2721
[16]   Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome [J].
Esteller, M ;
Avizienyte, E ;
Corn, PG ;
Lothe, RA ;
Baylin, SB ;
Aaltonen, LA ;
Herman, JG .
ONCOGENE, 2000, 19 (01) :164-168
[17]  
Esteller M, 2000, CANCER RES, V60, P4366
[18]   Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors [J].
Esteller, M ;
Silva, JM ;
Dominguez, G ;
Bonilla, F ;
Matias-Guiu, X ;
Lerma, E ;
Bussaglia, E ;
Prat, J ;
Harkes, IC ;
Repasky, EA ;
Gabrielson, E ;
Schutte, M ;
Baylin, SB ;
Herman, JG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) :564-569
[19]  
Esteller M, 2002, J NATL CANCER I, V94, P26
[20]   Cancer epigenetics takes center stage [J].
Feinberg, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :392-394